⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194506 | 0.70 | — | — | |
| SCHEMBL2403785 | 0.70 | — | — | |
| Carbon Dioxide SCHEMBL27411305 | 0.67 | — | — | |
| SCHEMBL27450269 | 0.67 | — | — | |
| SCHEMBL2882504 | 0.67 | — | — | |
| SCHEMBL1862942 | 0.67 | — | — | |
| Charcoal, Activated SCHEMBL31423781 | 0.67 | — | — | |
| SCHEMBL28958957 | 0.67 | — | — | |
| SCHEMBL29380 | 0.64 | — | — | |
| SCHEMBL9527000 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115379857-A | Use of polar extracts of Skeletonema in photodynamic therapy | 法国海洋开发研究所 | 2022-11-22 | — | — | CN | disclosed |
| CN-114773506-A | Catalyst for in-situ nucleation of polypropylene and preparation method and application thereof | 山东京博石油化工有限公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-2491928-A2 | Therapeutic agent for vitiligo and method of accelerating pigmentation | The University of Tokyo (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110034514-A1 | 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors | AMIRA PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | US | disclosed |
| US-7834037-B2 | 1,3,5-Substituted indole derivatives, e.g., 3-[3-tert-butylthio-1-[4-(6-methoxypyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-indol-2-yl]-2,2-dimethyl-propionic acid; used alone and in combination with other compounds for treating leukotriene-dependent diseases such as respiratory and cardiovascular | AMIRA PHARMACEUTICALS, INC. (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100222275-A1 | THERAPEUTIC AGENT FOR VITILIGO AND METHOD OF ACCELERATING PIGMENTATION | MARUHO CO., LTD (JP) | 2010-09-02 | — | — | US | disclosed |
| EP-2198887-A1 | THERAPEUTIC AGENT FOR LEUKODERMA AND METHOD FOR ACCELERATION OF PIGMENTATION | The University of Tokyo (JP) | 2010-06-23 | — | — | EP | disclosed |
| US-20090018170-A1 | 1,3,5-Substituted indole derivatives, e.g., 3-[3-tert-butylthio-1-[4-(6-methoxypyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-indol-2-yl]-2,2-dimethyl-propionic acid; used alone and in combination with other compounds for treating leukotriene-dependent diseases such as respiratory and cardiovascular | AMIRA PHARMACEUTICALS, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| EP-0556271-A1 | BIOLOGICAL ACTIVE MATERIAL COVALENTLY IMMOBILIZED ON TO AZLACTONE-FUNCTIONAL POLYMERIC SUPPORTS AND METHOD FOR PREPARING IT. | MINNESOTA MINING & MFG (US) | 1993-08-25 | — | — | EP | disclosed |